Retrospective data analysis of a German cohort of patients with active relapsing multiple sclerosis switching from anti-CD20 therapies to cladribine tablets and vice versa

被引：0
|
作者：
Konen, Franz Felix [1 ]
Pfeuffer, Steffen [2 ]
Jendretzky, Konstantin Fritz [1 ]
Gehring, Klaus [3 ]
Elias-Hamp, Birte
Suehs, Kurt-Wolfram [1 ]
Pawlitzki, Marc [4 ]
Meuth, Sven [4 ]
Kleinschnitz, Christoph [5 ,6 ]
Pul, Refik [5 ,6 ]
Skripuletz, Thomas [1 ]
机构：
[1] Hannover Med Sch, Dept Neurol, Hannover, Germany
[2] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, Dept Neurol, Giessen, Germany
[3] Neurozentrum Klosterforst, Itzehoe, Germany
[4] Heinrich Heine Univ Duesseldorf, Univ Hosp Duesseldorf, Dept Neurol, Dusseldorf, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany
[6] Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P293/939
引用
收藏
页码：328 / 330
页数：3
相关论文
共 50 条
  • [21] Follow-up of a French cohort of progressive multiple sclerosis patients treated with anti-CD20 antibodies
    Einsiedler, M.
    Kremer, L.
    Fleury, M.
    Collongues, N.
    De Seze, J.
    Bigaut, K.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 211 - 211
  • [22] Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
    Rollot, Fabien
    Couturier, Justine
    Casey, Romain
    Wiertlewski, Sandrine
    Debouverie, Marc
    Pelletier, Jean
    De Seze, Jerome
    Labauge, Pierre
    Ruet, Aurelie
    Thouvenot, Eric
    Ciron, Jonathan
    Berger, Eric
    Gout, Olivier
    Clavelou, Pierre
    Stankoff, Bruno
    Casez, Olivier
    Bourre, Bertrand
    Zephir, Helene
    Moreau, Thibault
    Lebrun-Frenay, Christine
    Maillart, Elisabeth
    Edan, Gilles
    Neau, Jean-Philippe
    Montcuquet, Alexis
    Cabre, Philippe
    Camdessanche, Jean-Philippe
    Defer, Gilles
    Ben Nasr, Haifa
    Maurousset, Aude
    Hankiewicz, Karolina
    Pottier, Corinne
    Leray, Emmanuelle
    Vukusic, Sandra
    Laplaud, David-Axel
    NEUROTHERAPEUTICS, 2022, 19 (02) : 476 - 490
  • [23] Response to COVID-19 mRNA Vaccination in Patients with Multiple Sclerosis on anti-CD20 Disease Modifying Therapies
    Wolf, Andrew
    Pratt, Robert W.
    Crooks, Kristy
    Borko, Tyler
    Gonzalez, Jose Parra
    Vollmer, Timothy
    Frazer-Abel, Ashley
    ANNALS OF NEUROLOGY, 2021, 90 : S179 - S180
  • [24] The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis
    Wu, Xin
    Tan, Xin
    Zhang, Jie
    Wang, Zilan
    Wu, Wenxue
    Wang, Shixin
    Liu, Yanfei
    Wang, Zhong
    CNS DRUGS, 2022, 36 (11) : 1155 - 1170
  • [25] The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis
    Xin Wu
    Xin Tan
    Jie Zhang
    Zilan Wang
    Wenxue Wu
    Shixin Wang
    Yanfei Liu
    Zhong Wang
    CNS Drugs, 2022, 36 : 1155 - 1170
  • [26] Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy
    Waede, Mie
    Voss, Lasse F.
    Kingo, Christina
    Moeller, Jesper B.
    Elkjaer, Maria L.
    Illes, Zsolt
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (10): : 2657 - 2672
  • [27] Treatment satisfaction in patients with highly-active relapsing multiple sclerosis treated with cladribine tablets: clarify-ms study interim analysis
    Brochet, B.
    Hupperts, R. H. Raymond
    Langdon, D.
    Solari, A.
    Piehl, F.
    Lechner-Scott, J.
    Montalban, X.
    Selmaj, K.
    Valis, M.
    Rejdak, K.
    Havrdova, E. Kubala
    Patti, F.
    Alexandri, N.
    Nolting, A.
    Keller, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 623 - 623
  • [28] Treatment Satisfaction in Patients with Highly-active Relapsing Multiple Sclerosis Treated with Cladribine Tablets: CLARIFY-MS Study Interim Analysis
    Brochet, Bruno
    Hupperts, Raymond
    Langdon, Dawn
    Solari, Alessandra
    Piehl, Fredrik
    Lechner-Scott, Jeanette
    Montalban, Xavier
    Selmaj, Krzysztof
    Valis, Martin
    Havrdova, Eva
    Rejdak, Konrad
    Patti, Francesco
    Alexandri, Nektaria
    Nolting, Axel
    Keller, Birgit
    NEUROLOGY, 2021, 96 (15)
  • [29] Late Onset Neutropenia in Multiple Sclerosis Patients who Received Anti-CD20 Therapies. Outcomes After Retreatment
    Aguirre, C.
    Meca-Lallana, V.
    Diaz-Perez, C.
    del Rio, B.
    Gonzalez-Martinez, A.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 96 - 96
  • [30] A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis
    Fox, Edward
    Lovett-Racke, Amy E.
    Gormley, Matthew
    Liu, Yue
    Petracca, Maria
    Cocozza, Sirio
    Shubin, Richard
    Wray, Sibyl
    Weiss, Michael S.
    Bosco, Jenna A.
    Power, Sean A.
    Mok, Koby
    Inglese, Matilde
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (03) : 420 - 429
12345